nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—SLC22A2—Progesterone—uterine cancer	0.0854	0.132	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—uterine cancer	0.0762	0.117	CbGbCtD
Zidovudine—CYP2A6—Progesterone—uterine cancer	0.0681	0.105	CbGbCtD
Zidovudine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0507	0.0781	CbGbCtD
Zidovudine—ABCG2—Dactinomycin—uterine cancer	0.05	0.077	CbGbCtD
Zidovudine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0354	0.0545	CbGbCtD
Zidovudine—ABCG2—Carboplatin—uterine cancer	0.0336	0.0518	CbGbCtD
Zidovudine—CYP2C8—Progesterone—uterine cancer	0.0336	0.0517	CbGbCtD
Zidovudine—ABCG2—Etoposide—uterine cancer	0.0282	0.0435	CbGbCtD
Zidovudine—CYP2C19—Progesterone—uterine cancer	0.0282	0.0434	CbGbCtD
Zidovudine—CYP2C9—Progesterone—uterine cancer	0.0234	0.0361	CbGbCtD
Zidovudine—ABCB1—Progesterone—uterine cancer	0.0227	0.035	CbGbCtD
Zidovudine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0206	0.0317	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—uterine cancer	0.0192	0.0296	CbGbCtD
Zidovudine—ABCB1—Dactinomycin—uterine cancer	0.018	0.0278	CbGbCtD
Zidovudine—CYP2C8—Etoposide—uterine cancer	0.015	0.0231	CbGbCtD
Zidovudine—CYP3A4—Progesterone—uterine cancer	0.0136	0.021	CbGbCtD
Zidovudine—ABCB1—Etoposide—uterine cancer	0.0102	0.0157	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—uterine cancer	0.00694	0.0107	CbGbCtD
Zidovudine—CYP3A4—Etoposide—uterine cancer	0.0061	0.00939	CbGbCtD
Zidovudine—TERT—epithelium—uterine cancer	0.00417	0.0604	CbGeAlD
Zidovudine—CYP3A4—Doxorubicin—uterine cancer	0.00416	0.0064	CbGbCtD
Zidovudine—SLC28A1—renal system—uterine cancer	0.00394	0.0571	CbGeAlD
Zidovudine—TERT—uterus—uterine cancer	0.00344	0.0499	CbGeAlD
Zidovudine—TERT—female reproductive system—uterine cancer	0.00309	0.0449	CbGeAlD
Zidovudine—TK1—epithelium—uterine cancer	0.00287	0.0416	CbGeAlD
Zidovudine—TERT—female gonad—uterine cancer	0.00282	0.0408	CbGeAlD
Zidovudine—TK1—endometrium—uterine cancer	0.00257	0.0373	CbGeAlD
Zidovudine—TK1—mammalian vulva—uterine cancer	0.00249	0.0361	CbGeAlD
Zidovudine—TK1—uterus—uterine cancer	0.00237	0.0344	CbGeAlD
Zidovudine—TK1—female reproductive system—uterine cancer	0.00213	0.0309	CbGeAlD
Zidovudine—TK1—female gonad—uterine cancer	0.00194	0.0281	CbGeAlD
Zidovudine—TK1—vagina—uterine cancer	0.00193	0.0279	CbGeAlD
Zidovudine—SLC29A2—female reproductive system—uterine cancer	0.00176	0.0256	CbGeAlD
Zidovudine—SLC29A2—vagina—uterine cancer	0.00159	0.0231	CbGeAlD
Zidovudine—UGT2B7—renal system—uterine cancer	0.00149	0.0216	CbGeAlD
Zidovudine—SLC22A11—renal system—uterine cancer	0.00145	0.021	CbGeAlD
Zidovudine—SLC22A7—renal system—uterine cancer	0.00141	0.0205	CbGeAlD
Zidovudine—ABCC5—uterine cervix—uterine cancer	0.00127	0.0184	CbGeAlD
Zidovudine—SLC22A2—renal system—uterine cancer	0.00126	0.0182	CbGeAlD
Zidovudine—TK1—lymph node—uterine cancer	0.00125	0.0181	CbGeAlD
Zidovudine—ABCC5—decidua—uterine cancer	0.00121	0.0175	CbGeAlD
Zidovudine—UGT2B7—female reproductive system—uterine cancer	0.00119	0.0173	CbGeAlD
Zidovudine—SLC22A11—female reproductive system—uterine cancer	0.00116	0.0168	CbGeAlD
Zidovudine—SLC29A2—lymph node—uterine cancer	0.00103	0.0149	CbGeAlD
Zidovudine—ABCC5—female gonad—uterine cancer	0.000866	0.0126	CbGeAlD
Zidovudine—ABCC5—vagina—uterine cancer	0.00086	0.0125	CbGeAlD
Zidovudine—ABCC4—renal system—uterine cancer	0.000823	0.0119	CbGeAlD
Zidovudine—SLC22A8—renal system—uterine cancer	0.000817	0.0118	CbGeAlD
Zidovudine—ABCG2—myometrium—uterine cancer	0.000798	0.0116	CbGeAlD
Zidovudine—CYP2A6—vagina—uterine cancer	0.000771	0.0112	CbGeAlD
Zidovudine—ABCC4—uterus—uterine cancer	0.000733	0.0106	CbGeAlD
Zidovudine—ABCC4—female reproductive system—uterine cancer	0.000659	0.00956	CbGeAlD
Zidovudine—ABCG2—uterine cervix—uterine cancer	0.000621	0.00901	CbGeAlD
Zidovudine—ABCC4—female gonad—uterine cancer	0.0006	0.0087	CbGeAlD
Zidovudine—CYP2C8—renal system—uterine cancer	0.000598	0.00867	CbGeAlD
Zidovudine—ABCG2—decidua—uterine cancer	0.000592	0.00859	CbGeAlD
Zidovudine—CYP2C8—endometrium—uterine cancer	0.000578	0.00838	CbGeAlD
Zidovudine—ABCG2—endometrium—uterine cancer	0.000562	0.00815	CbGeAlD
Zidovudine—ABCC5—lymph node—uterine cancer	0.000556	0.00807	CbGeAlD
Zidovudine—ABCG2—mammalian vulva—uterine cancer	0.000543	0.00788	CbGeAlD
Zidovudine—ABCG2—uterus—uterine cancer	0.000518	0.00751	CbGeAlD
Zidovudine—CYP2C19—vagina—uterine cancer	0.000496	0.00719	CbGeAlD
Zidovudine—CYP2C8—female reproductive system—uterine cancer	0.000479	0.00694	CbGeAlD
Zidovudine—CYP2C8—vagina—uterine cancer	0.000433	0.00628	CbGeAlD
Zidovudine—CYP2C9—female reproductive system—uterine cancer	0.000425	0.00617	CbGeAlD
Zidovudine—ABCG2—female gonad—uterine cancer	0.000423	0.00614	CbGeAlD
Zidovudine—ABCG2—vagina—uterine cancer	0.000421	0.00611	CbGeAlD
Zidovudine—CYP3A4—renal system—uterine cancer	0.000405	0.00587	CbGeAlD
Zidovudine—ALB—lymph node—uterine cancer	0.000398	0.00578	CbGeAlD
Zidovudine—ABCB1—myometrium—uterine cancer	0.000394	0.00571	CbGeAlD
Zidovudine—ABCC4—lymph node—uterine cancer	0.000386	0.00559	CbGeAlD
Zidovudine—CYP3A4—female reproductive system—uterine cancer	0.000324	0.0047	CbGeAlD
Zidovudine—ABCB1—epithelium—uterine cancer	0.000309	0.00448	CbGeAlD
Zidovudine—ABCB1—uterine cervix—uterine cancer	0.000306	0.00444	CbGeAlD
Zidovudine—ABCB1—decidua—uterine cancer	0.000292	0.00423	CbGeAlD
Zidovudine—ABCB1—renal system—uterine cancer	0.000287	0.00416	CbGeAlD
Zidovudine—ABCB1—endometrium—uterine cancer	0.000277	0.00402	CbGeAlD
Zidovudine—ABCG2—lymph node—uterine cancer	0.000272	0.00395	CbGeAlD
Zidovudine—ABCB1—mammalian vulva—uterine cancer	0.000268	0.00389	CbGeAlD
Zidovudine—ABCB1—uterus—uterine cancer	0.000255	0.0037	CbGeAlD
Zidovudine—ABCB1—female reproductive system—uterine cancer	0.000229	0.00333	CbGeAlD
Zidovudine—Dermatitis—Progesterone—uterine cancer	0.000217	0.00108	CcSEcCtD
Zidovudine—Phlebitis—Doxorubicin—uterine cancer	0.000216	0.00107	CcSEcCtD
Zidovudine—Headache—Progesterone—uterine cancer	0.000216	0.00107	CcSEcCtD
Zidovudine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000214	0.00106	CcSEcCtD
Zidovudine—Decreased appetite—Dactinomycin—uterine cancer	0.000212	0.00105	CcSEcCtD
Zidovudine—Dysgeusia—Etoposide—uterine cancer	0.000212	0.00105	CcSEcCtD
Zidovudine—Fatigue—Dactinomycin—uterine cancer	0.00021	0.00104	CcSEcCtD
Zidovudine—Back pain—Etoposide—uterine cancer	0.000209	0.00104	CcSEcCtD
Zidovudine—ABCB1—female gonad—uterine cancer	0.000209	0.00303	CbGeAlD
Zidovudine—Pain—Dactinomycin—uterine cancer	0.000208	0.00103	CcSEcCtD
Zidovudine—Muscle spasms—Etoposide—uterine cancer	0.000208	0.00103	CcSEcCtD
Zidovudine—ABCB1—vagina—uterine cancer	0.000208	0.00301	CbGeAlD
Zidovudine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00102	CcSEcCtD
Zidovudine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000205	0.00102	CcSEcCtD
Zidovudine—Nausea—Progesterone—uterine cancer	0.000205	0.00102	CcSEcCtD
Zidovudine—Feeling abnormal—Dactinomycin—uterine cancer	0.000201	0.000996	CcSEcCtD
Zidovudine—Ill-defined disorder—Etoposide—uterine cancer	0.0002	0.000994	CcSEcCtD
Zidovudine—Anaemia—Etoposide—uterine cancer	0.0002	0.00099	CcSEcCtD
Zidovudine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000199	0.000988	CcSEcCtD
Zidovudine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000199	0.000985	CcSEcCtD
Zidovudine—Affect lability—Epirubicin—uterine cancer	0.000198	0.000982	CcSEcCtD
Zidovudine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.000977	CcSEcCtD
Zidovudine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.000976	CcSEcCtD
Zidovudine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000196	0.00097	CcSEcCtD
Zidovudine—Malaise—Etoposide—uterine cancer	0.000195	0.000966	CcSEcCtD
Zidovudine—Vertigo—Etoposide—uterine cancer	0.000194	0.000963	CcSEcCtD
Zidovudine—Leukopenia—Etoposide—uterine cancer	0.000193	0.000959	CcSEcCtD
Zidovudine—Body temperature increased—Dactinomycin—uterine cancer	0.000193	0.000955	CcSEcCtD
Zidovudine—Abdominal pain—Dactinomycin—uterine cancer	0.000193	0.000955	CcSEcCtD
Zidovudine—Mood swings—Epirubicin—uterine cancer	0.000191	0.000945	CcSEcCtD
Zidovudine—Loss of consciousness—Etoposide—uterine cancer	0.00019	0.000942	CcSEcCtD
Zidovudine—Cough—Etoposide—uterine cancer	0.000189	0.000935	CcSEcCtD
Zidovudine—Convulsion—Etoposide—uterine cancer	0.000187	0.000928	CcSEcCtD
Zidovudine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.00092	CcSEcCtD
Zidovudine—Chest pain—Etoposide—uterine cancer	0.000184	0.000912	CcSEcCtD
Zidovudine—Affect lability—Doxorubicin—uterine cancer	0.000183	0.000908	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000183	0.000906	CcSEcCtD
Zidovudine—Discomfort—Etoposide—uterine cancer	0.000182	0.000901	CcSEcCtD
Zidovudine—Breast disorder—Epirubicin—uterine cancer	0.000182	0.000901	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000181	0.000898	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000181	0.000898	CcSEcCtD
Zidovudine—Nasopharyngitis—Epirubicin—uterine cancer	0.00018	0.000892	CcSEcCtD
Zidovudine—Confusional state—Etoposide—uterine cancer	0.000178	0.000882	CcSEcCtD
Zidovudine—Anaphylactic shock—Etoposide—uterine cancer	0.000176	0.000874	CcSEcCtD
Zidovudine—Mood swings—Doxorubicin—uterine cancer	0.000176	0.000874	CcSEcCtD
Zidovudine—Asthenia—Dactinomycin—uterine cancer	0.000175	0.000867	CcSEcCtD
Zidovudine—Influenza—Epirubicin—uterine cancer	0.000174	0.000862	CcSEcCtD
Zidovudine—Dysphagia—Epirubicin—uterine cancer	0.000174	0.000862	CcSEcCtD
Zidovudine—Thrombocytopenia—Etoposide—uterine cancer	0.000173	0.000856	CcSEcCtD
Zidovudine—Skin disorder—Etoposide—uterine cancer	0.000171	0.000849	CcSEcCtD
Zidovudine—Hyperhidrosis—Etoposide—uterine cancer	0.00017	0.000845	CcSEcCtD
Zidovudine—Pancreatitis—Epirubicin—uterine cancer	0.00017	0.000845	CcSEcCtD
Zidovudine—Breast disorder—Doxorubicin—uterine cancer	0.000168	0.000834	CcSEcCtD
Zidovudine—Anorexia—Etoposide—uterine cancer	0.000168	0.000833	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000168	0.000831	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000168	0.000831	CcSEcCtD
Zidovudine—Diarrhoea—Dactinomycin—uterine cancer	0.000167	0.000827	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000166	0.000825	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—uterine cancer	0.000165	0.000818	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—uterine cancer	0.000163	0.000806	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—uterine cancer	0.000163	0.000806	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—uterine cancer	0.000161	0.000797	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—uterine cancer	0.000161	0.000797	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—uterine cancer	0.000161	0.000796	CcSEcCtD
Zidovudine—Paraesthesia—Etoposide—uterine cancer	0.000158	0.000785	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—uterine cancer	0.000158	0.000782	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—uterine cancer	0.000157	0.00078	CcSEcCtD
Zidovudine—Dyspnoea—Etoposide—uterine cancer	0.000157	0.00078	CcSEcCtD
Zidovudine—Somnolence—Etoposide—uterine cancer	0.000157	0.000777	CcSEcCtD
Zidovudine—Vomiting—Dactinomycin—uterine cancer	0.000155	0.000768	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000154	0.000762	CcSEcCtD
Zidovudine—Rash—Dactinomycin—uterine cancer	0.000154	0.000762	CcSEcCtD
Zidovudine—Decreased appetite—Etoposide—uterine cancer	0.000153	0.00076	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—uterine cancer	0.000153	0.000757	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000152	0.000755	CcSEcCtD
Zidovudine—Fatigue—Etoposide—uterine cancer	0.000152	0.000754	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000152	0.000753	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—uterine cancer	0.000151	0.000749	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—uterine cancer	0.000151	0.000749	CcSEcCtD
Zidovudine—Constipation—Etoposide—uterine cancer	0.000151	0.000748	CcSEcCtD
Zidovudine—Pain—Etoposide—uterine cancer	0.000151	0.000748	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—uterine cancer	0.00015	0.000746	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—uterine cancer	0.00015	0.000746	CcSEcCtD
Zidovudine—Sweating—Epirubicin—uterine cancer	0.000149	0.000737	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—uterine cancer	0.000149	0.000737	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—uterine cancer	0.000148	0.000733	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000147	0.000727	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—uterine cancer	0.000146	0.000725	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—uterine cancer	0.000145	0.000721	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—uterine cancer	0.000145	0.000721	CcSEcCtD
Zidovudine—Feeling abnormal—Etoposide—uterine cancer	0.000145	0.000721	CcSEcCtD
Zidovudine—Nausea—Dactinomycin—uterine cancer	0.000145	0.000718	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—uterine cancer	0.000145	0.000717	CcSEcCtD
Zidovudine—Gastrointestinal pain—Etoposide—uterine cancer	0.000144	0.000715	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000142	0.000705	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000141	0.000697	CcSEcCtD
Zidovudine—Urticaria—Etoposide—uterine cancer	0.00014	0.000695	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—uterine cancer	0.00014	0.000693	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—uterine cancer	0.00014	0.000693	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—uterine cancer	0.000139	0.000692	CcSEcCtD
Zidovudine—Body temperature increased—Etoposide—uterine cancer	0.000139	0.000691	CcSEcCtD
Zidovudine—Abdominal pain—Etoposide—uterine cancer	0.000139	0.000691	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—uterine cancer	0.000139	0.00069	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—uterine cancer	0.000138	0.000685	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—uterine cancer	0.000137	0.000682	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—uterine cancer	0.000137	0.000681	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—uterine cancer	0.000137	0.000678	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—uterine cancer	0.000137	0.000678	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—uterine cancer	0.000136	0.000676	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000136	0.000672	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—uterine cancer	0.000135	0.000671	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—uterine cancer	0.000135	0.000667	CcSEcCtD
Zidovudine—ABCB1—lymph node—uterine cancer	0.000134	0.00195	CbGeAlD
Zidovudine—Agranulocytosis—Doxorubicin—uterine cancer	0.000134	0.000664	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—uterine cancer	0.000132	0.000652	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—uterine cancer	0.000129	0.00064	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—uterine cancer	0.000129	0.00064	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—uterine cancer	0.000129	0.000638	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—uterine cancer	0.000128	0.000634	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000127	0.00063	CcSEcCtD
Zidovudine—Asthenia—Etoposide—uterine cancer	0.000127	0.000627	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000126	0.000627	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—uterine cancer	0.000126	0.000626	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—uterine cancer	0.000125	0.000622	CcSEcCtD
Zidovudine—Chills—Epirubicin—uterine cancer	0.000125	0.000619	CcSEcCtD
Zidovudine—Pruritus—Etoposide—uterine cancer	0.000125	0.000619	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—uterine cancer	0.000122	0.000604	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—uterine cancer	0.000122	0.000604	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—uterine cancer	0.000121	0.000601	CcSEcCtD
Zidovudine—Erythema—Epirubicin—uterine cancer	0.000121	0.000601	CcSEcCtD
Zidovudine—Diarrhoea—Etoposide—uterine cancer	0.000121	0.000598	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—uterine cancer	0.000119	0.000592	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—uterine cancer	0.000119	0.000592	CcSEcCtD
Zidovudine—Tension—Epirubicin—uterine cancer	0.000119	0.000589	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—uterine cancer	0.000119	0.000588	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—uterine cancer	0.000118	0.000583	CcSEcCtD
Zidovudine—Back pain—Epirubicin—uterine cancer	0.000117	0.000581	CcSEcCtD
Zidovudine—Dizziness—Etoposide—uterine cancer	0.000117	0.000578	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—uterine cancer	0.000116	0.000577	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000116	0.000575	CcSEcCtD
Zidovudine—Chills—Doxorubicin—uterine cancer	0.000115	0.000573	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—uterine cancer	0.000113	0.000559	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—uterine cancer	0.000112	0.000557	CcSEcCtD
Zidovudine—Vomiting—Etoposide—uterine cancer	0.000112	0.000556	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—uterine cancer	0.000112	0.000556	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—uterine cancer	0.000112	0.000556	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—uterine cancer	0.000112	0.000555	CcSEcCtD
Zidovudine—Rash—Etoposide—uterine cancer	0.000111	0.000551	CcSEcCtD
Zidovudine—Dermatitis—Etoposide—uterine cancer	0.000111	0.000551	CcSEcCtD
Zidovudine—Headache—Etoposide—uterine cancer	0.00011	0.000548	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—uterine cancer	0.00011	0.000548	CcSEcCtD
Zidovudine—Tension—Doxorubicin—uterine cancer	0.00011	0.000545	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—uterine cancer	0.00011	0.000544	CcSEcCtD
Zidovudine—Malaise—Epirubicin—uterine cancer	0.000109	0.000542	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—uterine cancer	0.000109	0.00054	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—uterine cancer	0.000109	0.00054	CcSEcCtD
Zidovudine—Syncope—Epirubicin—uterine cancer	0.000109	0.000539	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—uterine cancer	0.000108	0.000538	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—uterine cancer	0.000108	0.000537	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—uterine cancer	0.000108	0.000534	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—uterine cancer	0.000106	0.000528	CcSEcCtD
Zidovudine—Cough—Epirubicin—uterine cancer	0.000106	0.000524	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—uterine cancer	0.000105	0.00052	CcSEcCtD
Zidovudine—Nausea—Etoposide—uterine cancer	0.000105	0.000519	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000104	0.000516	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—uterine cancer	0.000104	0.000514	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—uterine cancer	0.000103	0.000511	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—uterine cancer	0.000103	0.000511	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—uterine cancer	0.000103	0.000511	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—uterine cancer	0.000103	0.000509	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000102	0.000508	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—uterine cancer	0.000102	0.000505	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—uterine cancer	0.000101	0.000501	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—uterine cancer	0.000101	0.000499	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—uterine cancer	0.0001	0.000498	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—uterine cancer	0.0001	0.000497	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—uterine cancer	9.97e-05	0.000494	CcSEcCtD
Zidovudine—Oedema—Epirubicin—uterine cancer	9.88e-05	0.00049	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—uterine cancer	9.88e-05	0.00049	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—uterine cancer	9.85e-05	0.000488	CcSEcCtD
Zidovudine—Cough—Doxorubicin—uterine cancer	9.78e-05	0.000485	CcSEcCtD
Zidovudine—Shock—Epirubicin—uterine cancer	9.72e-05	0.000482	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—uterine cancer	9.71e-05	0.000481	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—uterine cancer	9.69e-05	0.000481	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—uterine cancer	9.68e-05	0.00048	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—uterine cancer	9.6e-05	0.000476	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—uterine cancer	9.55e-05	0.000474	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—uterine cancer	9.54e-05	0.000473	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—uterine cancer	9.54e-05	0.000473	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—uterine cancer	9.54e-05	0.000473	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—uterine cancer	9.51e-05	0.000471	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.47e-05	0.00047	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—uterine cancer	9.43e-05	0.000467	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—uterine cancer	9.42e-05	0.000467	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—uterine cancer	9.22e-05	0.000457	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—uterine cancer	9.15e-05	0.000453	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—uterine cancer	9.15e-05	0.000453	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—uterine cancer	9e-05	0.000447	CcSEcCtD
Zidovudine—Shock—Doxorubicin—uterine cancer	9e-05	0.000446	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—uterine cancer	8.97e-05	0.000445	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—uterine cancer	8.95e-05	0.000444	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—uterine cancer	8.94e-05	0.000443	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—uterine cancer	8.88e-05	0.00044	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—uterine cancer	8.88e-05	0.00044	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—uterine cancer	8.84e-05	0.000438	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—uterine cancer	8.81e-05	0.000437	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—uterine cancer	8.79e-05	0.000436	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—uterine cancer	8.72e-05	0.000432	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—uterine cancer	8.7e-05	0.000431	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—uterine cancer	8.59e-05	0.000426	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—uterine cancer	8.53e-05	0.000423	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—uterine cancer	8.52e-05	0.000423	CcSEcCtD
Zidovudine—Pain—Epirubicin—uterine cancer	8.45e-05	0.000419	CcSEcCtD
Zidovudine—Constipation—Epirubicin—uterine cancer	8.45e-05	0.000419	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.33e-05	0.000413	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—uterine cancer	8.27e-05	0.00041	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—uterine cancer	8.21e-05	0.000407	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—uterine cancer	8.15e-05	0.000404	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—uterine cancer	8.14e-05	0.000404	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—uterine cancer	8.13e-05	0.000403	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—uterine cancer	8.08e-05	0.000401	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—uterine cancer	8.05e-05	0.000399	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—uterine cancer	7.95e-05	0.000394	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.9e-05	0.000392	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—uterine cancer	7.88e-05	0.000391	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—uterine cancer	7.85e-05	0.000389	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—uterine cancer	7.82e-05	0.000388	CcSEcCtD
Zidovudine—Pain—Doxorubicin—uterine cancer	7.82e-05	0.000388	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—uterine cancer	7.81e-05	0.000387	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—uterine cancer	7.81e-05	0.000387	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—uterine cancer	7.54e-05	0.000374	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—uterine cancer	7.48e-05	0.000371	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—uterine cancer	7.27e-05	0.00036	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—uterine cancer	7.23e-05	0.000358	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—uterine cancer	7.23e-05	0.000358	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—uterine cancer	7.09e-05	0.000352	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—uterine cancer	6.99e-05	0.000347	CcSEcCtD
Zidovudine—Diarrhoea—Epirubicin—uterine cancer	6.76e-05	0.000335	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—uterine cancer	6.56e-05	0.000325	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—uterine cancer	6.54e-05	0.000324	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—uterine cancer	6.47e-05	0.000321	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—uterine cancer	6.28e-05	0.000312	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—uterine cancer	6.26e-05	0.00031	CcSEcCtD
Zidovudine—Rash—Epirubicin—uterine cancer	6.23e-05	0.000309	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—uterine cancer	6.23e-05	0.000309	CcSEcCtD
Zidovudine—Headache—Epirubicin—uterine cancer	6.19e-05	0.000307	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—uterine cancer	6.05e-05	0.0003	CcSEcCtD
Zidovudine—Nausea—Epirubicin—uterine cancer	5.87e-05	0.000291	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—uterine cancer	5.81e-05	0.000288	CcSEcCtD
Zidovudine—Rash—Doxorubicin—uterine cancer	5.77e-05	0.000286	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—uterine cancer	5.76e-05	0.000286	CcSEcCtD
Zidovudine—Headache—Doxorubicin—uterine cancer	5.73e-05	0.000284	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—uterine cancer	5.43e-05	0.000269	CcSEcCtD
Zidovudine—ABCC5—Metabolism—CYP19A1—uterine cancer	3.22e-05	0.000403	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.2e-05	0.000399	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.2e-05	0.000399	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.19e-05	0.000399	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IRF1—uterine cancer	3.18e-05	0.000398	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.18e-05	0.000398	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SRD5A2—uterine cancer	3.18e-05	0.000397	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NDUFB11—uterine cancer	3.18e-05	0.000397	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	3.15e-05	0.000394	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SMAD3—uterine cancer	3.15e-05	0.000394	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.15e-05	0.000393	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.1e-05	0.000388	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.1e-05	0.000387	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.09e-05	0.000386	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKR1C3—uterine cancer	3.05e-05	0.000381	CbGpPWpGaD
Zidovudine—ABCC5—Disease—FGFR2—uterine cancer	3.01e-05	0.000376	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ERBB2—uterine cancer	3e-05	0.000375	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.93e-05	0.000366	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—POLD1—uterine cancer	2.92e-05	0.000365	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.91e-05	0.000364	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MTHFR—uterine cancer	2.89e-05	0.000362	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—POLD1—uterine cancer	2.89e-05	0.000361	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.85e-05	0.000356	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.85e-05	0.000356	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCL8—uterine cancer	2.85e-05	0.000356	CbGpPWpGaD
Zidovudine—TERT—Disease—KRAS—uterine cancer	2.81e-05	0.000351	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NDUFB11—uterine cancer	2.78e-05	0.000348	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SRD5A2—uterine cancer	2.78e-05	0.000348	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CDKN1B—uterine cancer	2.78e-05	0.000347	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.77e-05	0.000346	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKR1C1—uterine cancer	2.73e-05	0.000341	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKR1C1—uterine cancer	2.7e-05	0.000338	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.69e-05	0.000336	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—POLD1—uterine cancer	2.65e-05	0.000332	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CTNNB1—uterine cancer	2.63e-05	0.000328	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.62e-05	0.000327	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.000325	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.000325	CbGpPWpGaD
Zidovudine—TERT—Disease—PIK3CA—uterine cancer	2.58e-05	0.000322	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.58e-05	0.000322	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTEN—uterine cancer	2.56e-05	0.00032	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.53e-05	0.000316	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKR1C1—uterine cancer	2.48e-05	0.00031	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EP300—uterine cancer	2.44e-05	0.000305	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—RRM2—uterine cancer	2.44e-05	0.000304	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—MTHFR—uterine cancer	2.42e-05	0.000303	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—RRM2—uterine cancer	2.41e-05	0.000301	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PIK3CA—uterine cancer	2.39e-05	0.000298	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—uterine cancer	2.39e-05	0.000298	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.39e-05	0.000298	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—STK11—uterine cancer	2.38e-05	0.000297	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.38e-05	0.000297	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—DCN—uterine cancer	2.36e-05	0.000295	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—DCN—uterine cancer	2.34e-05	0.000292	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.34e-05	0.000292	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—uterine cancer	2.31e-05	0.000289	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.31e-05	0.000289	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—STAR—uterine cancer	2.31e-05	0.000289	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKR1B1—uterine cancer	2.3e-05	0.000287	CbGpPWpGaD
Zidovudine—ALB—Metabolism—STAR—uterine cancer	2.3e-05	0.000287	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	2.29e-05	0.000287	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRAS—uterine cancer	2.28e-05	0.000285	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.28e-05	0.000285	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.27e-05	0.000284	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP11A1—uterine cancer	2.23e-05	0.000278	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—RRM2—uterine cancer	2.21e-05	0.000276	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP11A1—uterine cancer	2.2e-05	0.000275	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—EP300—uterine cancer	2.2e-05	0.000275	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.16e-05	0.00027	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—DCN—uterine cancer	2.15e-05	0.000268	CbGpPWpGaD
Zidovudine—TERT—Disease—AKT1—uterine cancer	2.11e-05	0.000263	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKR1C3—uterine cancer	2.1e-05	0.000263	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKR1C3—uterine cancer	2.08e-05	0.00026	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—uterine cancer	2.08e-05	0.00026	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—STAR—uterine cancer	2.06e-05	0.000258	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.06e-05	0.000258	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NRAS—uterine cancer	2.06e-05	0.000257	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.04e-05	0.000255	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.04e-05	0.000255	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.02e-05	0.000253	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—STAR—uterine cancer	2.01e-05	0.000252	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKR1B1—uterine cancer	2.01e-05	0.000252	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.99e-05	0.000249	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—uterine cancer	1.97e-05	0.000246	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—uterine cancer	1.95e-05	0.000244	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.91e-05	0.000239	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.9e-05	0.000237	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—uterine cancer	1.89e-05	0.000236	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—STAR—uterine cancer	1.88e-05	0.000235	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.000235	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.86e-05	0.000232	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.83e-05	0.000228	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—POLD1—uterine cancer	1.81e-05	0.000227	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CA—uterine cancer	1.81e-05	0.000226	CbGpPWpGaD
Zidovudine—ALB—Metabolism—POLD1—uterine cancer	1.8e-05	0.000225	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.8e-05	0.000225	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—MTHFR—uterine cancer	1.79e-05	0.000223	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—uterine cancer	1.77e-05	0.000221	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—uterine cancer	1.76e-05	0.00022	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1B—uterine cancer	1.75e-05	0.000218	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—uterine cancer	1.75e-05	0.000218	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.72e-05	0.000214	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.72e-05	0.000214	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.7e-05	0.000212	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000211	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—uterine cancer	1.67e-05	0.000209	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CTNNB1—uterine cancer	1.65e-05	0.000206	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP19A1—uterine cancer	1.64e-05	0.000205	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—STK11—uterine cancer	1.64e-05	0.000205	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.63e-05	0.000203	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—STK11—uterine cancer	1.62e-05	0.000203	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.62e-05	0.000203	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—POLD1—uterine cancer	1.62e-05	0.000202	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—uterine cancer	1.61e-05	0.000201	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—POLD1—uterine cancer	1.58e-05	0.000197	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—uterine cancer	1.57e-05	0.000197	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EP300—uterine cancer	1.53e-05	0.000192	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.53e-05	0.000191	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.51e-05	0.000189	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RRM2—uterine cancer	1.51e-05	0.000189	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—uterine cancer	1.5e-05	0.000188	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RRM2—uterine cancer	1.5e-05	0.000188	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—STK11—uterine cancer	1.49e-05	0.000186	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.49e-05	0.000186	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.48e-05	0.000185	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—POLD1—uterine cancer	1.48e-05	0.000184	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—uterine cancer	1.48e-05	0.000184	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—DCN—uterine cancer	1.47e-05	0.000183	CbGpPWpGaD
Zidovudine—ALB—Metabolism—DCN—uterine cancer	1.46e-05	0.000182	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—uterine cancer	1.44e-05	0.000179	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.43e-05	0.000178	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.41e-05	0.000176	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000173	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000172	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP11A1—uterine cancer	1.37e-05	0.000172	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.36e-05	0.00017	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RRM2—uterine cancer	1.35e-05	0.000169	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—uterine cancer	1.35e-05	0.000168	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—uterine cancer	1.33e-05	0.000166	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RRM2—uterine cancer	1.32e-05	0.000165	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—DCN—uterine cancer	1.31e-05	0.000164	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.31e-05	0.000163	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000162	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—EP300—uterine cancer	1.29e-05	0.000161	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—DCN—uterine cancer	1.28e-05	0.00016	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.24e-05	0.000155	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—STAR—uterine cancer	1.24e-05	0.000155	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—uterine cancer	1.24e-05	0.000154	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.23e-05	0.000154	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—MTHFR—uterine cancer	1.23e-05	0.000154	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RRM2—uterine cancer	1.23e-05	0.000154	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000152	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.2e-05	0.00015	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—DCN—uterine cancer	1.19e-05	0.000149	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.17e-05	0.000146	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000146	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.15e-05	0.000143	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKR1C3—uterine cancer	1.14e-05	0.000142	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—uterine cancer	1.14e-05	0.000142	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000141	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—MTHFR—uterine cancer	1.12e-05	0.00014	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000133	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—uterine cancer	1.05e-05	0.000131	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—STK11—uterine cancer	1.02e-05	0.000127	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.02e-05	0.000127	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000126	CbGpPWpGaD
Zidovudine—ALB—Metabolism—STK11—uterine cancer	1.01e-05	0.000126	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EP300—uterine cancer	9.94e-06	0.000124	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—uterine cancer	9.94e-06	0.000124	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—POLD1—uterine cancer	9.73e-06	0.000122	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.55e-06	0.000119	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—uterine cancer	9.51e-06	0.000119	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.49e-06	0.000119	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—uterine cancer	9.48e-06	0.000118	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—uterine cancer	9.42e-06	0.000118	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—uterine cancer	9.3e-06	0.000116	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—uterine cancer	9.27e-06	0.000116	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.1e-06	0.000114	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.1e-06	0.000114	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.08e-06	0.000113	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—STK11—uterine cancer	9.08e-06	0.000113	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.05e-06	0.000113	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP19A1—uterine cancer	8.86e-06	0.000111	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—STK11—uterine cancer	8.86e-06	0.000111	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.52e-06	0.000106	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.28e-06	0.000103	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—STK11—uterine cancer	8.28e-06	0.000103	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.13e-06	0.000102	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RRM2—uterine cancer	8.11e-06	0.000101	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—uterine cancer	8.01e-06	0.0001	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—DCN—uterine cancer	7.88e-06	9.84e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.77e-06	9.71e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—uterine cancer	7.77e-06	9.71e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—MTHFR—uterine cancer	7.64e-06	9.55e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—MTHFR—uterine cancer	7.6e-06	9.5e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.42e-06	9.27e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.41e-06	9.26e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—uterine cancer	7.36e-06	9.19e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—uterine cancer	7.12e-06	8.89e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—uterine cancer	7.01e-06	8.76e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.01e-06	8.76e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—uterine cancer	6.85e-06	8.56e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—MTHFR—uterine cancer	6.82e-06	8.52e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—uterine cancer	6.81e-06	8.5e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—uterine cancer	6.78e-06	8.47e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.73e-06	8.42e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.7e-06	8.37e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—MTHFR—uterine cancer	6.66e-06	8.32e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—uterine cancer	6.53e-06	8.16e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—uterine cancer	6.47e-06	8.08e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—uterine cancer	6.22e-06	7.78e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—MTHFR—uterine cancer	6.22e-06	7.77e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.01e-06	7.51e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—uterine cancer	6.01e-06	7.51e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—uterine cancer	5.94e-06	7.42e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—uterine cancer	5.73e-06	7.16e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.48e-06	6.85e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—STK11—uterine cancer	5.46e-06	6.82e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.46e-06	6.82e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—uterine cancer	4.83e-06	6.04e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—uterine cancer	4.78e-06	5.98e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—uterine cancer	4.39e-06	5.49e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—uterine cancer	4.25e-06	5.31e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—uterine cancer	4.23e-06	5.28e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MTHFR—uterine cancer	4.1e-06	5.13e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—uterine cancer	4.05e-06	5.07e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—uterine cancer	4.03e-06	5.04e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—uterine cancer	3.95e-06	4.93e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—uterine cancer	3.91e-06	4.88e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—uterine cancer	3.79e-06	4.74e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—uterine cancer	3.7e-06	4.63e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—uterine cancer	3.62e-06	4.52e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—uterine cancer	3.59e-06	4.48e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—uterine cancer	3.53e-06	4.41e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—uterine cancer	3.46e-06	4.32e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—uterine cancer	3.3e-06	4.12e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—uterine cancer	3e-06	3.75e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—uterine cancer	2.98e-06	3.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.68e-06	3.35e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.61e-06	3.27e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—uterine cancer	2.45e-06	3.06e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.44e-06	3.05e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—uterine cancer	2.44e-06	3.04e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—uterine cancer	2.28e-06	2.85e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—uterine cancer	2.19e-06	2.73e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—uterine cancer	2.18e-06	2.72e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—uterine cancer	2.13e-06	2.67e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—uterine cancer	1.99e-06	2.49e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.61e-06	2.01e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—uterine cancer	1.32e-06	1.64e-05	CbGpPWpGaD
